Conatus Pharmaceuticals, Inc.. (CNAT) NASDAQ
$0.56 - (-)
Market Cap: $18.58M
As of 05/26/20 04:00 PM EDT. Market closed.
Conatus Pharmaceuticals, Inc.. (CNAT)
NASDAQ
$0.56
- (-)
Market Cap: $18.58M
As of 05/26/20 04:00 PM EDT. Market closed.
Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active ... read more
Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Pascoe Richard W | President, CEO & Director | Mar 30, 2021 | Buy | $1.14 | 20,000 | 22,800 | 30,000 | Mar 30, 2021, 06:28 PM |
Pascoe Richard W | President, CEO & Director | Dec 03, 2020 | Buy | $1.24 | 10,000 | 12,394 | 10,000 | Dec 07, 2020, 04:06 PM |
Marshall Keith W | EVP, COO & CFO | May 22, 2020 | Option Exercise | $0.56 | 18,615 | 10,424 | 19,885 | May 27, 2020, 06:09 AM |
Spada Alfred P. | EVP, R&D and CSO | May 22, 2020 | Option Exercise | $0.56 | 12,960 | 7,258 | 19,595 | May 27, 2020, 06:05 AM |
Mento Steven J | Director | May 22, 2020 | Option Exercise | $0.56 | 31,428 | 17,600 | 39,572 | May 27, 2020, 06:04 AM |
Smith Edward F III | SVP, Reg Affairs and QA | May 14, 2018 | Option Exercise | $3.31 | 4,690 | 15,524 | 9,151 | Feb 11, 2019, 04:20 PM |
Smith Edward F III | SVP, Reg Affairs and QA | Nov 14, 2018 | Option Exercise | $3.15 | 1,724 | 5,431 | 10,875 | Feb 11, 2019, 04:20 PM |
RIPLEY DANIEL L. | SVP, Bus Dev, P&A Mgmt | Nov 14, 2018 | Option Exercise | $3.15 | 1,861 | 5,862 | 32,431 | Feb 11, 2019, 04:19 PM |
RIPLEY DANIEL L. | SVP, Bus Dev, P&A Mgmt | May 14, 2018 | Option Exercise | $3.31 | 1,290 | 4,270 | 30,570 | Feb 11, 2019, 04:19 PM |
Mento Steven J | President, CEO & Director | May 04, 2018 | Option Exercise | $0.99 | 60,000 | 59,400 | 60,000 | May 07, 2018, 07:46 PM |
Spada Alfred P. | EVP, R&D and CSO | Feb 27, 2018 | Option Exercise | $1.24 | 12,121 | 15,030 | 12,121 | Mar 01, 2018, 04:08 PM |
Smith Edward F III | SVP, Reg Affairs and QA | Nov 14, 2017 | Option Exercise | $3.48 | 4,461 | 15,524 | 4,461 | Feb 05, 2018, 05:03 PM |
RIPLEY DANIEL L. | SVP, Bus Dev, P&A Mgmt | Nov 14, 2017 | Option Exercise | $3.48 | 818 | 2,847 | 29,280 | Feb 05, 2018, 05:02 PM |
RIPLEY DANIEL L. | SVP, Bus Dev, P&A Mgmt | May 12, 2017 | Option Exercise | $1.70 | 761 | 1,294 | 28,462 | Feb 05, 2018, 05:02 PM |
Cashion Charles | SVP, Finance, CFO and Sec. | Jan 09, 2017 | Option Exercise | $0.99 | 42,424 | 42,000 | 42,424 | Jan 11, 2017, 04:01 PM |
Mento Steven J | President, CEO & Director | Dec 20, 2016 | Option Exercise | $1.21 | 41,414 | 50,091 | 41,414 | Dec 22, 2016, 04:04 PM |
Van Wart Harold | Director | Oct 27, 2016 | Option Exercise | $0.25 | 18,181 | 4,545 | 18,181 | Oct 31, 2016, 04:37 PM |
KISNER DANIEL L | Director | Apr 08, 2015 | Buy | $5.75 | 4,000 | 23,000 | 7,145 | Apr 10, 2015, 04:02 PM |
HALE DAVID F | Director | Jan 08, 2014 | Option Exercise | $0.99 | 12,121 | 12,000 | 24,242 | Jan 10, 2014, 05:07 PM |
HALE DAVID F | Director | Sep 26, 2013 | Option Exercise | $2.31 | 12,121 | 28,000 | 12,121 | Sep 27, 2013, 04:29 PM |
Aberdare GP III, L.L.C. | 10% Owner | Jul 30, 2013 | Option Exercise | $11.00 | 251 | 2,761 | 49,949 | Aug 01, 2013, 07:18 PM |
Aberdare GP III, L.L.C. | 10% Owner | Jul 30, 2013 | Option Exercise | $11.00 | 10,614 | 116,754 | 2,121,992 | Aug 01, 2013, 07:18 PM |
Aberdare GP III, L.L.C. | 10% Owner | Jul 30, 2013 | Buy | $11.00 | 2,470 | 27,170 | 52,419 | Aug 01, 2013, 07:18 PM |
Aberdare GP III, L.L.C. | 10% Owner | Jul 30, 2013 | Buy | $11.00 | 104,952 | 1,154,472 | 2,226,944 | Aug 01, 2013, 07:18 PM |
Aberdare GP III, L.L.C. | 10% Owner | Jul 30, 2013 | Sale | $11.00 | 14 | 154 | 49,698 | Aug 01, 2013, 07:18 PM |
Aberdare GP III, L.L.C. | 10% Owner | Jul 30, 2013 | Sale | $11.00 | 552 | 6,072 | 2,111,378 | Aug 01, 2013, 07:18 PM |
Aberdare GP III, L.L.C. | 10% Owner | Jul 30, 2013 | Option Exercise | $0.08 | 73,395 | 6,055 | 2,111,930 | Aug 01, 2013, 07:18 PM |
Aberdare GP III, L.L.C. | 10% Owner | Jul 30, 2013 | Option Exercise | $0.08 | 1,727 | 142 | 49,712 | Aug 01, 2013, 07:18 PM |
Perret Marc Olivier | Director | Jul 30, 2013 | Option Exercise | $11.00 | 16,742 | 184,162 | 1,321,795 | Aug 01, 2013, 07:18 PM |
Perret Marc Olivier | Director | Jul 30, 2013 | Buy | $11.00 | 165,525 | 1,820,775 | 1,487,320 | Aug 01, 2013, 07:18 PM |
Perret Marc Olivier | Director | Jul 30, 2013 | Sale | $11.00 | 352 | 3,872 | 1,305,053 | Aug 01, 2013, 07:18 PM |
Mento Steven J | President, CEO & Director | Jul 30, 2013 | Option Exercise | $11.00 | 1,395 | 15,345 | 371,869 | Aug 01, 2013, 07:16 PM |
Mento Steven J | President, CEO & Director | Jul 30, 2013 | Buy | $11.00 | 13,800 | 151,800 | 385,669 | Aug 01, 2013, 07:16 PM |
KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Option Exercise | $11.00 | 10,614 | 116,754 | 2,121,992 | Aug 01, 2013, 07:16 PM |
KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Option Exercise | $11.00 | 251 | 2,761 | 49,949 | Aug 01, 2013, 07:16 PM |
KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Buy | $11.00 | 104,952 | 1,154,472 | 2,226,944 | Aug 01, 2013, 07:16 PM |
KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Buy | $11.00 | 2,470 | 27,170 | 52,419 | Aug 01, 2013, 07:16 PM |
KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Sale | $11.00 | 14 | 154 | 49,698 | Aug 01, 2013, 07:16 PM |
KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Sale | $11.00 | 552 | 6,072 | 2,111,378 | Aug 01, 2013, 07:16 PM |
KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Option Exercise | $0.08 | 1,727 | 142 | 49,712 | Aug 01, 2013, 07:16 PM |
KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Option Exercise | $0.08 | 73,395 | 6,055 | 2,111,930 | Aug 01, 2013, 07:16 PM |
Malik Shahzad | Director | Jul 30, 2013 | Option Exercise | $11.00 | 19,223 | 211,453 | 1,976,782 | Aug 01, 2013, 07:14 PM |
Malik Shahzad | Director | Jul 30, 2013 | Buy | $11.00 | 190,054 | 2,090,594 | 2,166,836 | Aug 01, 2013, 07:14 PM |
Malik Shahzad | Director | Jul 30, 2013 | Sale | $11.00 | 535 | 5,885 | 1,957,559 | Aug 01, 2013, 07:14 PM |
Malik Shahzad | Director | Jul 30, 2013 | Option Exercise | $0.08 | 70,003 | 5,775 | 1,958,094 | Aug 01, 2013, 07:14 PM |
LACASSE LOUIS P | Director | Jul 30, 2013 | Option Exercise | $11.00 | 12,537 | 137,907 | 685,937 | Aug 01, 2013, 07:12 PM |
LACASSE LOUIS P | Director | Jul 30, 2013 | Buy | $11.00 | 123,950 | 1,363,450 | 809,887 | Aug 01, 2013, 07:12 PM |
HALE DAVID F | Director | Jul 30, 2013 | Option Exercise | $11.00 | 261 | 2,871 | 141,151 | Aug 01, 2013, 07:11 PM |
HALE DAVID F | Director | Jul 30, 2013 | Buy | $11.00 | 2,588 | 28,468 | 143,739 | Aug 01, 2013, 07:11 PM |
COOPERATIVE GILDE HEALTHCARE II U.A. | 10% Owner | Jul 30, 2013 | Option Exercise | $11.00 | 16,742 | 184,162 | 1,321,795 | Aug 01, 2013, 07:10 PM |
COOPERATIVE GILDE HEALTHCARE II U.A. | 10% Owner | Jul 30, 2013 | Buy | $11.00 | 165,525 | 1,820,775 | 1,487,320 | Aug 01, 2013, 07:10 PM |
COOPERATIVE GILDE HEALTHCARE II U.A. | 10% Owner | Jul 30, 2013 | Sale | $11.00 | 352 | 3,872 | 1,305,053 | Aug 01, 2013, 07:10 PM |
ADVENT VENTURE PARTNERS LLP | 10% Owner | Jul 30, 2013 | Option Exercise | $11.00 | 19,223 | 211,453 | 1,976,782 | Aug 01, 2013, 07:09 PM |
ADVENT VENTURE PARTNERS LLP | 10% Owner | Jul 30, 2013 | Buy | $11.00 | 190,054 | 2,090,594 | 2,166,836 | Aug 01, 2013, 07:09 PM |
ADVENT VENTURE PARTNERS LLP | 10% Owner | Jul 30, 2013 | Sale | $11.00 | 535 | 5,885 | 1,957,559 | Aug 01, 2013, 07:09 PM |
ADVENT VENTURE PARTNERS LLP | 10% Owner | Jul 30, 2013 | Option Exercise | $0.08 | 70,003 | 5,775 | 1,958,094 | Aug 01, 2013, 07:09 PM |
Scopa James Paul | Director | Jul 30, 2013 | Option Exercise | $11.00 | 16,716 | 183,876 | 1,026,815 | Aug 01, 2013, 02:21 PM |
Scopa James Paul | Director | Jul 30, 2013 | Buy | $11.00 | 165,265 | 1,817,915 | 1,192,080 | Aug 01, 2013, 02:21 PM |
EVNIN LUKE | 10% Owner | Jul 30, 2013 | Option Exercise | $11.00 | 16,716 | 183,876 | 1,026,815 | Aug 01, 2013, 02:19 PM |
EVNIN LUKE | 10% Owner | Jul 30, 2013 | Buy | $11.00 | 165,265 | 1,817,915 | 1,192,080 | Aug 01, 2013, 02:19 PM |
MPM BioVentures IV QP LP | 10% Owner | Jul 30, 2013 | Option Exercise | $11.00 | 16,716 | 183,876 | 1,026,815 | Aug 01, 2013, 02:18 PM |
MPM BioVentures IV QP LP | 10% Owner | Jul 30, 2013 | Buy | $11.00 | 165,265 | 1,817,915 | 1,192,080 | Aug 01, 2013, 02:18 PM |